Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer.
BACKGROUND: Human papillomavirus-associated oropharynx squamous cell carcinoma (HPV-OPSCC) has no known pre-malignant lesion. While vaccination offers future primary prevention, there is current interest in secondary prevention. The feasibility of clinical evaluation of individuals at increased risk for HPV-OPSCC is unclear. METHODS: Individuals with risk factors for HPV-OPSCC were enrolled in a prospective study (MOUTH). Participants positive for biomarkers associated with HPV-OPSCC were eligible for a clinical evaluation which comprised a head and neck examination and imaging with ultrasound and/or magnetic resonance imaging (MRI). This study was designed to evaluate feasibility of clinical evaluation in a screening study. RESULTS: Three hundred and eighty-four participants were eligible for clinical evaluation. Of the 384, 204 (53%) completed a head and neck examination or imaging. Of these, 66 (32%) completed MRI (n = 51) and/or ultrasound (n = 64) studies. CONCLUSIONS: Clinical evaluations, including head and neck examination and imaging, are feasible in the context of a screening study for HPV-OPSCC.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Squamous Cell Carcinoma of Head and Neck
- Prospective Studies
- Papillomavirus Infections
- Papillomaviridae
- Otorhinolaryngology
- Oropharyngeal Neoplasms
- Humans
- Human Papillomavirus Viruses
- Head and Neck Neoplasms
- Carcinoma, Squamous Cell
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Squamous Cell Carcinoma of Head and Neck
- Prospective Studies
- Papillomavirus Infections
- Papillomaviridae
- Otorhinolaryngology
- Oropharyngeal Neoplasms
- Humans
- Human Papillomavirus Viruses
- Head and Neck Neoplasms
- Carcinoma, Squamous Cell